Autres langues Swedish Orphan Biovitrum AB

Actions

SOBI

SE0000872095

Marché Fermé - Nasdaq Stockholm Autres places de cotation 12:59:48 30/04/2024			Varia. 5j.	Varia. 1 janv.
285,4 ^SEK	+0,71%		+8,60%	+6,89%

26/04	Sobi obtient l'avis favorable du comité de réglementation de l'UE pour son médicament contre l'hémophilie A	MT
26/04	Sobi reçoit un avis positif du CHMP recommandant l'approbation de l'efanesoctocog alfa pour le traitement hebdomadaire de l'hémophilie A	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sobi Wins EU Regulatory Panel's Positive Opinion for Hemophilia A Drug	26/04
Sobi Receives Positive CHMP Opinion Recommending Approval of efanesoctocog alfa for Once-Weekly Treatment of Haemophilia A	26/04
Sobi's SEK10 Billion Note Program Gets Regulatory Nod in Sweden	26/04
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A	26/04
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus	26/04
Swedish Orphan Biovitrum : 25 april - Q1 2024 rapport	25/04
Swedish Orphan Biovitrum : 25 April - Q1 2024 report	25/04
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio	25/04
Swedish Orphan Biovitrum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Swedish Orphan Biovitrum AB Provides Earnings Guidance for 2024	25/04
Invitation: Sobi's Q1 2024 report	15/04
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)	04/04
Swedish Orphan Biovitrum : Sobi publishes Annual and sustainability report for 2023	02/04
Sobi publishes Annual and sustainability report for 2023	02/04
Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP	25/03
Certain Shares of Swedish Orphan Biovitrum AB are subject to a Lock-Up Agreement Ending on 14-MAR-2024.	14/03
OPINIONES DE LOS ANALISTAS DEL DÍA : Inditex, Acciona Energia, Merlin Properties, Tod's, Euronext, ...	22/02
Sobi to Expand in South Korea via Rare Disease JV with Handok	13/02
US Futures, European Stocks Mixed	12/02
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	12/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Swedish Orphan Biovitrum AB

Actions

SOBI

SE0000872095

Autres langues

Filtres